Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERIBRAIN – Eribulin in brain metastases from HER2-negative breast cancer
2018-001027-40Phase 2Completed
- Sponsor
- Institut Paoli-Calmettes
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eribulin in breast cancer, sponsored by Institut Paoli-Calmettes. Started Jun 2018; status: completed.
02
Drugs
eribulin
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2018-001027-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001027-40.